Test-system for estimation of activity of GSK-3 inhibitors as antihypoxants and differentiation of endothelial progenitors in vitro
DOI:
https://doi.org/10.18413/2313-8971-2016-2-1-58-62Abstract
A model test-system was developed for validation in vitro of antihypoxic and endothelio-differentiating activity of newly created glycogen synthase kinase-3 inhibitors in comparison with the reference drug β4-thymosin.
Keywords:
glycogen synthase kinase-3, GSK-3; β4-thymosin, hypoxia, ischemia, endotheliumDownloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Research Results in Pharmacology
This work is licensed under a Creative Commons Attribution 4.0 International License.